Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Interest Coverage Ratio (2020 - 2025)

Apellis Pharmaceuticals has reported Interest Coverage Ratio over the past 6 years, most recently at 4.71 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 4.71 for Q4 2025, down 155.77% from a year ago — trailing twelve months through Dec 2025 was 1.25 (up 222.27% YoY), and the annual figure for FY2025 was 1.25, up 222.26%.
  • Interest Coverage Ratio for Q4 2025 was 4.71 at Apellis Pharmaceuticals, down from 19.79 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for APLS hit a ceiling of 241.84 in Q4 2021 and a floor of 56.09 in Q3 2021.
  • Median Interest Coverage Ratio over the past 5 years was 12.01 (2022), compared with a mean of 0.67.
  • Peak annual rise in Interest Coverage Ratio hit 1686.14% in 2021, while the deepest fall reached 311.25% in 2021.
  • Apellis Pharmaceuticals' Interest Coverage Ratio stood at 241.84 in 2021, then crashed by 108.77% to 21.2 in 2022, then surged by 305.21% to 43.51 in 2023, then crashed by 80.57% to 8.45 in 2024, then crashed by 155.77% to 4.71 in 2025.
  • The last three reported values for Interest Coverage Ratio were 4.71 (Q4 2025), 19.79 (Q3 2025), and 2.98 (Q2 2025) per Business Quant data.